LU82364A1 - Composition pharmaceutique cicatrisante contenant un agent antifongique/antibacterien et du sucre,et ses applications - Google Patents

Composition pharmaceutique cicatrisante contenant un agent antifongique/antibacterien et du sucre,et ses applications Download PDF

Info

Publication number: LU82364A1
Authority: LU; Luxembourg
Prior art keywords: wound; composition according; wounds; tissue; sugar
Prior art date: 1979-04-18

Application number

LU82364A

Other languages

English (en)

French (fr)

Original Assignee

Knutson R

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-04-18

Filing date

1980-04-16

Publication date

1981-12-02

1980-04-16 Application filed by Knutson R filed Critical Knutson R

1981-12-02 Publication of LU82364A1 publication Critical patent/LU82364A1/fr

Links

239000003242 anti bacterial agent Substances 0.000 title claims description 44
229940121375 antifungal agent Drugs 0.000 title claims description 15
230000000843 anti-fungal effect Effects 0.000 title claims description 14
239000003429 antifungal agent Substances 0.000 title claims description 10
230000035876 healing Effects 0.000 title description 45
239000008194 pharmaceutical composition Substances 0.000 title description 2
208000027418 Wounds and injury Diseases 0.000 claims description 196
206010052428 Wound Diseases 0.000 claims description 194
239000000203 mixture Substances 0.000 claims description 123
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 claims description 64
238000011282 treatment Methods 0.000 claims description 56
229940064804 betadine Drugs 0.000 claims description 32
229960001621 povidone-iodine Drugs 0.000 claims description 32
229920000153 Povidone-iodine Polymers 0.000 claims description 31
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 28
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
239000002674 ointment Substances 0.000 claims description 23
239000000470 constituent Substances 0.000 claims description 22
238000004140 cleaning Methods 0.000 claims description 17
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 13
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
229930006000 Sucrose Natural products 0.000 claims description 10
230000000844 anti-bacterial effect Effects 0.000 claims description 8
239000003795 chemical substances by application Substances 0.000 claims description 8
235000012907 honey Nutrition 0.000 claims description 8
239000005720 sucrose Substances 0.000 claims description 8
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
235000013379 molasses Nutrition 0.000 claims description 7
229930091371 Fructose Natural products 0.000 claims description 5
239000005715 Fructose Substances 0.000 claims description 5
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
235000021552 granulated sugar Nutrition 0.000 claims description 5
230000002009 allergenic effect Effects 0.000 claims description 4
239000008121 dextrose Substances 0.000 claims description 4
238000003860 storage Methods 0.000 claims description 4
239000008103 glucose Substances 0.000 claims description 3
235000000346 sugar Nutrition 0.000 description 69
210000001519 tissue Anatomy 0.000 description 47
239000003814 drug Substances 0.000 description 46
208000015181 infectious disease Diseases 0.000 description 34
208000004210 Pressure Ulcer Diseases 0.000 description 30
229940088710 antibiotic agent Drugs 0.000 description 30
210000003811 finger Anatomy 0.000 description 30
OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 30
229940079593 drug Drugs 0.000 description 29
239000000047 product Substances 0.000 description 20
206010063560 Excessive granulation tissue Diseases 0.000 description 19
210000000988 bone and bone Anatomy 0.000 description 19
210000001126 granulation tissue Anatomy 0.000 description 19
241000282414 Homo sapiens Species 0.000 description 16
206010011985 Decubitus ulcer Diseases 0.000 description 15
238000002266 amputation Methods 0.000 description 15
239000000463 material Substances 0.000 description 15
206010000269 abscess Diseases 0.000 description 14
208000014674 injury Diseases 0.000 description 14
230000036407 pain Effects 0.000 description 14
230000006378 damage Effects 0.000 description 13
208000034693 Laceration Diseases 0.000 description 12
208000002565 Open Fractures Diseases 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
210000002683 foot Anatomy 0.000 description 11
238000000034 method Methods 0.000 description 11
229920000036 polyvinylpyrrolidone Polymers 0.000 description 11
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 11
229940069328 povidone Drugs 0.000 description 11
206010012601 diabetes mellitus Diseases 0.000 description 10
208000025865 Ulcer Diseases 0.000 description 9
238000011161 development Methods 0.000 description 9
230000018109 developmental process Effects 0.000 description 9
230000037390 scarring Effects 0.000 description 9
210000003127 knee Anatomy 0.000 description 8
230000002829 reductive effect Effects 0.000 description 8
230000029663 wound healing Effects 0.000 description 8
208000032843 Hemorrhage Diseases 0.000 description 7
206010031252 Osteomyelitis Diseases 0.000 description 7
230000000740 bleeding effect Effects 0.000 description 7
238000001804 debridement Methods 0.000 description 7
230000007547 defect Effects 0.000 description 7
239000004615 ingredient Substances 0.000 description 7
238000011221 initial treatment Methods 0.000 description 7
229960004793 sucrose Drugs 0.000 description 7
238000001356 surgical procedure Methods 0.000 description 7
208000010392 Bone Fractures Diseases 0.000 description 6
206010017076 Fracture Diseases 0.000 description 6
208000033809 Suppuration Diseases 0.000 description 6
238000005299 abrasion Methods 0.000 description 6
230000003115 biocidal effect Effects 0.000 description 6
230000008859 change Effects 0.000 description 6
230000002354 daily effect Effects 0.000 description 6
230000003902 lesion Effects 0.000 description 6
239000004081 narcotic agent Substances 0.000 description 6
231100000241 scar Toxicity 0.000 description 6
230000035945 sensitivity Effects 0.000 description 6
210000004872 soft tissue Anatomy 0.000 description 6
229910001220 stainless steel Inorganic materials 0.000 description 6
239000010935 stainless steel Substances 0.000 description 6
231100000397 ulcer Toxicity 0.000 description 6
208000025962 Crush injury Diseases 0.000 description 5
208000023329 Gun shot wound Diseases 0.000 description 5
210000003423 ankle Anatomy 0.000 description 5
238000011109 contamination Methods 0.000 description 5
239000012530 fluid Substances 0.000 description 5
238000002156 mixing Methods 0.000 description 5
230000009885 systemic effect Effects 0.000 description 5
208000002874 Acne Vulgaris Diseases 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
206010006802 Burns second degree Diseases 0.000 description 4
206010030113 Oedema Diseases 0.000 description 4
206010000496 acne Diseases 0.000 description 4
230000003444 anaesthetic effect Effects 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000000969 carrier Substances 0.000 description 4
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
229910052740 iodine Inorganic materials 0.000 description 4
229940090589 keflex Drugs 0.000 description 4
210000002414 leg Anatomy 0.000 description 4
229940127249 oral antibiotic Drugs 0.000 description 4
239000011505 plaster Substances 0.000 description 4
230000009467 reduction Effects 0.000 description 4
239000000344 soap Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
238000005406 washing Methods 0.000 description 4
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
206010006797 Burns first degree Diseases 0.000 description 3
206010015150 Erythema Diseases 0.000 description 3
208000001034 Frostbite Diseases 0.000 description 3
241000233866 Fungi Species 0.000 description 3
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
206010028851 Necrosis Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
201000004681 Psoriasis Diseases 0.000 description 3
230000008901 benefit Effects 0.000 description 3
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
210000000981 epithelium Anatomy 0.000 description 3
231100000321 erythema Toxicity 0.000 description 3
230000006870 function Effects 0.000 description 3
230000002538 fungal effect Effects 0.000 description 3
239000008240 homogeneous mixture Substances 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000011630 iodine Substances 0.000 description 3
238000002483 medication Methods 0.000 description 3
230000017074 necrotic cell death Effects 0.000 description 3
235000019271 petrolatum Nutrition 0.000 description 3
238000000554 physical therapy Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
239000006188 syrup Substances 0.000 description 3
210000002435 tendon Anatomy 0.000 description 3
210000002303 tibia Anatomy 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
230000036269 ulceration Effects 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
206010006803 Burns third degree Diseases 0.000 description 2
206010056340 Diabetic ulcer Diseases 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
206010016334 Feeling hot Diseases 0.000 description 2
208000003790 Foot Ulcer Diseases 0.000 description 2
206010018852 Haematoma Diseases 0.000 description 2
241000282412 Homo Species 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
208000002260 Keloid Diseases 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
206010037660 Pyrexia Diseases 0.000 description 2
206010039203 Road traffic accident Diseases 0.000 description 2
206010039509 Scab Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
241000159243 Toxicodendron radicans Species 0.000 description 2
210000003447 amputation stump Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000004744 fabric Substances 0.000 description 2
238000011049 filling Methods 0.000 description 2
210000000245 forearm Anatomy 0.000 description 2
230000012010 growth Effects 0.000 description 2
210000004209 hair Anatomy 0.000 description 2
210000001255 hallux Anatomy 0.000 description 2
210000004247 hand Anatomy 0.000 description 2
230000023597 hemostasis Effects 0.000 description 2
238000007373 indentation Methods 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000002262 irrigation Effects 0.000 description 2
238000003973 irrigation Methods 0.000 description 2
210000001117 keloid Anatomy 0.000 description 2
238000002690 local anesthesia Methods 0.000 description 2
230000003641 microbiacidal effect Effects 0.000 description 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
239000003883 ointment base Substances 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000008929 regeneration Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
230000035807 sensation Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
230000008961 swelling Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000011269 treatment regimen Methods 0.000 description 2
239000002023 wood Substances 0.000 description 2
YKSVGLFNJPQDJE-YDMQLZBCSA-N (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4R,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid Chemical compound CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC2(O)CC(O)C(C(CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)O2)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1 YKSVGLFNJPQDJE-YDMQLZBCSA-N 0.000 description 1
FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
BSWWXRFVMJHFBN-UHFFFAOYSA-N 2,4,6-tribromophenol Chemical compound OC1=C(Br)C=C(Br)C=C1Br BSWWXRFVMJHFBN-UHFFFAOYSA-N 0.000 description 1
VFDASNWZZRLEAU-UHFFFAOYSA-N 3-bromo-4-[3-(2-bromo-4-carbamimidoylphenoxy)propoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.BrC1=CC(C(=N)N)=CC=C1OCCCOC1=CC=C(C(N)=N)C=C1Br VFDASNWZZRLEAU-UHFFFAOYSA-N 0.000 description 1
XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
241000238876 Acari Species 0.000 description 1
241000208140 Acer Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
206010048946 Anal abscess Diseases 0.000 description 1
208000027502 Ankle fracture Diseases 0.000 description 1
241000239290 Araneae Species 0.000 description 1
208000003014 Bites and Stings Diseases 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
206010007247 Carbuncle Diseases 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
241001137251 Corvidae Species 0.000 description 1
206010011732 Cyst Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
101100421144 Danio rerio selenoo1 gene Proteins 0.000 description 1
208000008960 Diabetic foot Diseases 0.000 description 1
206010012665 Diabetic gangrene Diseases 0.000 description 1
IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
201000000297 Erysipelas Diseases 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
206010017711 Gangrene Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010061978 Genital lesion Diseases 0.000 description 1
UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
CTETYYAZBPJBHE-UHFFFAOYSA-N Haloprogin Chemical compound ClC1=CC(Cl)=C(OCC#CI)C=C1Cl CTETYYAZBPJBHE-UHFFFAOYSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010021118 Hypotonia Diseases 0.000 description 1
241000976924 Inca Species 0.000 description 1
206010060820 Joint injury Diseases 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
206010024453 Ligament sprain Diseases 0.000 description 1
206010024774 Localised infection Diseases 0.000 description 1
244000062730 Melissa officinalis Species 0.000 description 1
235000010654 Melissa officinalis Nutrition 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000006670 Multiple fractures Diseases 0.000 description 1
101100202896 Mus musculus Selenoo gene Proteins 0.000 description 1
DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
208000005890 Neuroma Diseases 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
206010031256 Osteomyelitis chronic Diseases 0.000 description 1
206010034016 Paronychia Diseases 0.000 description 1
241000029132 Paronychia Species 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
208000000528 Pilonidal Sinus Diseases 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
206010061926 Purulence Diseases 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
208000003589 Spider Bites Diseases 0.000 description 1
208000010040 Sprains and Strains Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
206010042496 Sunburn Diseases 0.000 description 1
206010054830 Throat lesion Diseases 0.000 description 1
208000000558 Varicose Ulcer Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
208000022542 ankle injury Diseases 0.000 description 1
NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
235000008429 bread Nutrition 0.000 description 1
239000011449 brick Substances 0.000 description 1
230000001914 calming effect Effects 0.000 description 1
229960004348 candicidin Drugs 0.000 description 1
KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
239000008294 cold cream Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
230000009519 contusion Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000006071 cream Substances 0.000 description 1
ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
230000034994 death Effects 0.000 description 1
230000035614 depigmentation Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
229960004006 dibromopropamidine isethionate Drugs 0.000 description 1
235000013681 dietary sucrose Nutrition 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
229960002311 dithranol Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000004880 explosion Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
210000001145 finger joint Anatomy 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
238000009920 food preservation Methods 0.000 description 1
210000001061 forehead Anatomy 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
229960001235 gentian violet Drugs 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
229960002867 griseofulvin Drugs 0.000 description 1
DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
229960001906 haloprogin Drugs 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
208000031169 hemorrhagic disease Diseases 0.000 description 1
235000008216 herbs Nutrition 0.000 description 1
ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
229960004068 hexachlorophene Drugs 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
239000008311 hydrophilic ointment Substances 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
208000011379 keloid formation Diseases 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
238000009533 lab test Methods 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
235000014666 liquid concentrate Nutrition 0.000 description 1
JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
229940126601 medicinal product Drugs 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
210000001037 metacarpus Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000036640 muscle relaxation Effects 0.000 description 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229960000988 nystatin Drugs 0.000 description 1
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
229940124583 pain medication Drugs 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
238000009304 pastoral farming Methods 0.000 description 1
235000021400 peanut butter Nutrition 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
235000015108 pies Nutrition 0.000 description 1
235000013550 pizza Nutrition 0.000 description 1
229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
229940057847 polyethylene glycol 600 Drugs 0.000 description 1
229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
239000001294 propane Substances 0.000 description 1
AMCPECLBZPXAPB-UHFFFAOYSA-N propane-1,2,3-triol;sodium Chemical compound [Na].OCC(O)CO AMCPECLBZPXAPB-UHFFFAOYSA-N 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000037307 sensitive skin Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
229940099261 silvadene Drugs 0.000 description 1
UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
201000008261 skin carcinoma Diseases 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000012177 spermaceti Substances 0.000 description 1
229940084106 spermaceti Drugs 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
KWXCNODTHBHSIQ-UHFFFAOYSA-N sulfabromomethazine Chemical compound CC1=C(Br)C(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 KWXCNODTHBHSIQ-UHFFFAOYSA-N 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
239000003859 topical antiinfective agent Substances 0.000 description 1
229940126702 topical medication Drugs 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
230000001228 trophic effect Effects 0.000 description 1
GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
229960002703 undecylenic acid Drugs 0.000 description 1
210000001364 upper extremity Anatomy 0.000 description 1
229940044950 vaginal gel Drugs 0.000 description 1
239000000029 vaginal gel Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011800 void material Substances 0.000 description 1
239000003871 white petrolatum Substances 0.000 description 1
239000003357 wound healing promoting agent Substances 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1
229940118257 zinc undecylenate Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

LU82364A 1979-04-18 1980-04-16 Composition pharmaceutique cicatrisante contenant un agent antifongique/antibacterien et du sucre,et ses applications LU82364A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3116279A	1979-04-18	1979-04-18
US3116279		1979-04-18

Publications (1)

Publication Number	Publication Date
LU82364A1 true LU82364A1 (fr)	1981-12-02

Family

ID=21857946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU82364A LU82364A1 (fr)	1979-04-18	1980-04-16	Composition pharmaceutique cicatrisante contenant un agent antifongique/antibacterien et du sucre,et ses applications

Country Status (19)

Country	Link
JP (1)	JPH0617299B2 (de)
AT (1)	AT386744B (de)
AU (1)	AU536885B2 (de)
BE (1)	BE882829A (de)
CA (1)	CA1125650A (de)
CH (1)	CH653892A5 (de)
DE (1)	DE3014524A1 (de)
EG (1)	EG14319A (de)
ES (1)	ES8103551A1 (de)
FR (1)	FR2454303A1 (de)
GB (1)	GB2048070B (de)
IL (1)	IL59881A (de)
IN (1)	IN152625B (de)
IT (1)	IT1136180B (de)
LU (1)	LU82364A1 (de)
MX (1)	MX6178E (de)
NO (1)	NO801112L (de)
SE (1)	SE451178B (de)
SU (1)	SU1709895A3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ199071A (en) *	1980-12-08	1984-05-31	Johnson & Johnson Prod Inc	Surgical dressing activated charcoal impregnated with anti-microbial agent
US4518517A (en) *	1983-03-16	1985-05-21	Colgate-Palmolive Company	Non-antimicrobial deodorant cleansing composition
JPS6198260A (ja) *	1984-10-19	1986-05-16	新技術開発事業団	創傷治療材
NL8500774A (nl) *	1985-03-18	1986-10-16	Dagra Nv	Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
DE3525440A1 (de) *	1985-07-17	1987-01-22	Thiele Dr Ing Henry	Mittel zur behandlung von schuerf-, brand- und sonstigen wunden
GB8520664D0 (en) *	1985-08-17	1985-09-25	Euro Celtique Sa	Suppository
EP0221728B1 (de) *	1985-10-22	1992-07-15	Anthony N. Silvetti, Sr.	Monosaccharide enthaltende Zusammensetzung zum Heilen von Wunden
JPS6310731A (ja) *	1986-03-12	1988-01-18	Kowa Co	安定な損傷皮膚修復用製剤
GB8622012D0 (en) *	1986-09-12	1986-10-22	Euro Celtique Sa	Solid iodophor composition
JPH01502189A (ja) *	1986-12-08	1989-08-03	アルセコ・インコーポレイテッド	保存上安定な局所投与用組成物
US4847078A (en) *	1987-01-14	1989-07-11	Arseco, Inc.	Storage stable topical composition having moisture control agent
US5034421A (en) *	1988-12-13	1991-07-23	Fuisz Pharmaceutical Ltd.	Moderated spun fibrous system and method of manufacture
JPH01132515A (ja) *	1987-11-18	1989-05-25	Kowa Co	外用殺菌剤組成物
JPH0377828A (ja) *	1989-08-21	1991-04-03	Tanabe Seiyaku Co Ltd	乳房炎予防用ヨードホール組成物
JPH03167123A (ja) *	1989-11-24	1991-07-19	Tsutomu Ishibashi	褥瘡用医薬品
GB9102660D0 (en) *	1991-02-07	1991-03-27	Ultra Lab Ltd	Wound dressing materials
JP3583166B2 (ja) *	1994-06-27	2004-10-27	興和株式会社	損傷皮膚修復用粉末製剤
RU2146127C1 (ru) *	1996-08-07	2000-03-10	Закрытое акционерное общество "Агрофарм-Питер-Сиб"	Мазь для лечения инфицированных ран
RU2128989C1 (ru) *	1997-03-05	1999-04-20	Закрытое акционерное общество "Химмедсинтез"	Композиция антимикробного, противовоспалительного и регенерационного действия
DE19957918A1 (de)	1999-11-25	2001-06-13	Ulrich Doht	Desinfektionsreiniger zur Reinigung und Pflege sowie Verfahren zu seiner Herstellung
DE60008790T3 (de) *	1999-12-09	2009-12-10	Comvita Ltd., Paengaroa	Medizinische verbände enthaltend gelartigen honig
JP4841733B2 (ja) *	2001-01-31	2011-12-21	三笠製薬株式会社	創傷治療用製剤
DE102013018941A1 (de) *	2013-11-12	2015-05-13	Tosama Sanitetnega Materiala D.O.O.	Fluid zur Wundbehandlung und Wundauflage
WO2015198196A1 (en) *	2014-06-26	2015-12-30	Tenerelli Simone	Improved pharmaceutical composition for the protection and healing of pressure ulcers, diabetic ulcers and vascular ulcers
GB2572642B (en) *	2018-04-06	2021-03-31	Pellis Care Ltd	Treatment of diabetic foot ulcers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US434727A (en) *		1890-08-19		Lotion
US1611962A (en) *	1926-04-06	1926-12-28	Mats H Tolonen	Lotion
GB294734A (en) *	1927-05-23	1928-08-02	William Evans	A preparation for the cure of foot-rot in sheep, and for external application in other animal diseases
GB553564A (en) *	1941-08-25	1943-05-27	Charles Rudolph Hans Ritter	Iodization of textile fabrics
GB673578A (en) *	1949-08-18	1952-06-11	Upjohn Co	Dry ointment composition
US3859436A (en) *	1968-10-02	1975-01-07	Kolmar Laboratories	Sugar composition for topical application
US3767784A (en) *	1970-12-01	1973-10-23	S Gluck	Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3944506A (en) *	1973-08-17	1976-03-16	Barnes-Hind Pharmaceuticals, Inc.	Abradant skin cleanser containing a borate salt
JPS5843404B2 (ja) *	1974-05-20	1983-09-27	アンソ−ニエヌシルベツテイ	チリヨウヨウドレツシングノセイゾウホウ

1980
- 1980-04-11 AU AU57398/80A patent/AU536885B2/en not_active Ceased
- 1980-04-16 EG EG238/80A patent/EG14319A/xx active
- 1980-04-16 LU LU82364A patent/LU82364A1/fr unknown
- 1980-04-16 SE SE8002847A patent/SE451178B/sv not_active IP Right Cessation
- 1980-04-16 DE DE19803014524 patent/DE3014524A1/de not_active Ceased
- 1980-04-16 JP JP55051086A patent/JPH0617299B2/ja not_active Expired - Lifetime
- 1980-04-17 CH CH2978/80A patent/CH653892A5/de not_active IP Right Cessation
- 1980-04-17 NO NO801112A patent/NO801112L/no unknown
- 1980-04-17 ES ES490654A patent/ES8103551A1/es not_active Expired
- 1980-04-17 GB GB8012755A patent/GB2048070B/en not_active Expired
- 1980-04-17 SU SU802909300A patent/SU1709895A3/ru active
- 1980-04-17 BE BE0/200262A patent/BE882829A/fr not_active IP Right Cessation
- 1980-04-17 FR FR8008657A patent/FR2454303A1/fr active Granted
- 1980-04-18 AT AT0210680A patent/AT386744B/de not_active IP Right Cessation
- 1980-04-18 MX MX808765U patent/MX6178E/es unknown
- 1980-04-18 CA CA350,131A patent/CA1125650A/en not_active Expired
- 1980-04-18 IN IN449/CAL/80A patent/IN152625B/en unknown
- 1980-04-18 IT IT12515/80A patent/IT1136180B/it active
- 1980-04-18 IL IL59881A patent/IL59881A/xx unknown

Also Published As

Publication number	Publication date
ES490654A0 (es)	1981-03-16
CA1125650A (en)	1982-06-15
MX6178E (es)	1984-12-05
DE3014524A1 (de)	1980-10-30
NO801112L (no)	1980-10-20
SU1709895A3 (ru)	1992-01-30
BE882829A (fr)	1980-08-18
IL59881A0 (en)	1980-06-30
GB2048070A (en)	1980-12-10
ES8103551A1 (es)	1981-03-16
JPS55141409A (en)	1980-11-05
SE8002847L (sv)	1980-10-19
SE451178B (sv)	1987-09-14
ATA210680A (de)	1988-03-15
CH653892A5 (de)	1986-01-31
IN152625B (de)	1984-02-25
GB2048070B (en)	1983-09-01
IL59881A (en)	1983-12-30
AU5739880A (en)	1980-10-23
EG14319A (en)	1983-12-31
AT386744B (de)	1988-10-10
JPH0617299B2 (ja)	1994-03-09
AU536885B2 (en)	1984-05-31
FR2454303B1 (de)	1984-12-28
IT1136180B (it)	1986-08-27
IT8012515A0 (it)	1980-04-18
FR2454303A1 (fr)	1980-11-14

Publication	Publication Date	Title
LU82364A1 (fr)	1981-12-02	Composition pharmaceutique cicatrisante contenant un agent antifongique/antibacterien et du sucre,et ses applications
US4401651A (en)	1983-08-30	Wound-healing compositions containing povidone-iodine
US20040121020A1 (en)	2004-06-24	Composition
WO2016204958A1 (en)	2016-12-22	Petrolatum-based compositions comprising cationic biocides
KR20150113035A (ko)	2015-10-07	표면 상처의 치료를 위한 조성물 및 방법
EP0112852A1 (de)	1984-07-11	Pharmazeutische gelzusammensetzung.
US6780439B2 (en)	2004-08-24	Wound treatment solution and method for using same
FR2577806A1 (fr)	1986-08-29	Compositions dermatologiques
JP2019517533A (ja)	2019-06-24	皮膚の種々の損傷創面の治療の外用医薬組成物およびその調製方法
JP2024059876A (ja)	2024-05-01	創傷および皮膚障害を治療するためのタラ肝油で構成される局所用組成物
Doanh et al.	1996	The use of a water extract from the bark of Choerospondias axillaris in the treatment of second decree burns
Gaurav et al.	2023	Home remedies in dermatology
US7141252B2 (en)	2006-11-28	Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
JPS63243027A (ja)	1988-10-07	栄養性障害の局所治療に用いるジヒドロエルゴタミン及び／又はその塩を含有する薬剤とその製造方法
WO2009027823A2 (en)	2009-03-05	Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application.
JP3899267B2 (ja)	2007-03-28	皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用
Goertz et al.	2010	Clinical safety and efficacy of a novel thermoreversible polyhexanide-preserved wound covering gel
AU2003234758B2 (en)	2009-04-02	Composition
WO2015159206A1 (en)	2015-10-22	Copper alloy microparticles for use in the treatment of an external skin lesion
JP5766379B1 (ja)	2015-08-19	サルファ剤およびキトサン剤を含み、剤型が散剤である、ゲル形成剤
US12171796B2 (en)	2024-12-24	Hydrogel wound treatment
RU2803777C1 (ru)	2023-09-19	Восковая мазь "ВОСКОСАП"
AU2001242100B2 (en)	2006-09-14	Pharmaceutical gel composition
US20210030698A1 (en)	2021-02-04	Gel containing zerumbone from bitter ginger (zingiber zerumbet) for curative treatment of diabetic ulcers
TR2023015695A1 (tr)	2025-06-23	Yara ve yanik tedavi̇leri̇ i̇çi̇n topi̇kal formülasyon